Advertisement

Research Summaries

FDA Alert
FDA Alert
08/24/2023

Anthony Calabro, MA

Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023
Research Summary
Research Summary
08/23/2023

Jessica Ganga

Jessica Ganga
A team of researchers sought to associate a link between symptoms of insomnia and the incidence of stroke in adults.
08/23/2023
Research Summary
Research Summary
08/22/2023

Jessica Ganga

Jessica Ganga
The American Thoracic Society released a set of guidelines addressing the use of pulmonary rehabilitation in patients with chronic obstructive pulmonary disorder and other respiratory diseases.
08/22/2023
Research Summary
Research Summary
08/16/2023

Anthony Calabro, MA

Anthony Calabro, MA
In a post hoc analysis of two phase 3 trials, researchers set out to determine the impact of sex on tofacitinib in terms of efficacy, safety, and time to discontinuation.
08/16/2023
Research Summary
Research Summary
08/16/2023

Jessica Ganga

Jessica Ganga
Researchers evaluated the effect of therapeutic exercise to help reduce pain in patients with knee or hip osteoarthritis.
08/16/2023
Research Summary
Research Summary
08/15/2023

Jessica Ganga

Jessica Ganga
In a post hoc analysis of the ASPREE trial, a team of researchers sought to define the effects of low-dose daily aspirin use in elderly adults.
08/15/2023
Research Summary
Research Summary
08/15/2023

Anthony Calabro, MA

Anthony Calabro, MA
Can a dietary intervention known for reducing cardiovascular risk factors prevent cognitive decline in healthy older individuals? A team of researchers explored this question in a recent study.
08/15/2023
Research Summary
Research Summary
08/15/2023

Anthony Calabro, MA

Anthony Calabro, MA
Patients with HIV have up to double the risk of atherosclerotic cardiovascular disease compared with the general population.
08/15/2023
Research Summary
Research Summary
08/10/2023

Anthony Calabro, MA

Anthony Calabro, MA
In a post hoc analysis of the EXCEED study, researchers found that secukinumab and adalimumab—two biologic disease-modifying antirheumatic medications—showed similar efficacy in the resolution of enthesitis...
08/10/2023
FDA Alert
FDA Alert
08/10/2023

Jessica Ganga

Jessica Ganga
The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.
08/10/2023